Blog2025-08-12T11:54:14-03:00
  • blog banner

Passarini Blog

New ANVISA System: 3 Essential Compliance Rules and the 5-Year Risk

New ANVISA Scheduling System: 3 Compliance Rules You Need to Master (And the 5-Year Record Keeping Risk) The end of the Parlatório and ANVISA's new digital era: Understand how Ordinance 54/2021 and automation demand Compliance 4.0 to avoid rejections and ensure the legal security of [...]

ANVISA Revolution: AFE and AE Are Now Automatic!

The End of Waiting: ANVISA Automates AFE and AE, Transforming Brazil’s Regulatory Routine The Authorization to Operate (AFE) and Special Authorization (AE) are foundational documents for any company seeking to operate in a market regulated by the Brazilian Health Regulatory Agency (ANVISA), covering sectors such [...]

Devices to America: How U.S. Tariffs Are Changing Medical Device Exports

The “Tarifaço” and the Changing Export Routes of Brazilian Medical Devices The term “tarifaço” refers to the steep tariffs imposed by the United States on certain imported products — in this case, Brazilian medical devices — which increase the cost of direct access to the [...]

DDR and DUIMP: How ANVISA’s Import Rules Stand

ANVISA Confirms Continuity of Direct Imports via DDR ANVISA has recently published the new Import Manual, confirming that the Declaration of the Registration Holder (DDR) will remain valid. This document allows the holder of a product registered in Brazil to authorize third parties to carry [...]

ANVISA Sets New Rule for Good Practice Certificate Validity

ANVISA Changes How Certificate Validity is Counted, Providing Clarity for Renewals The Brazilian Health Regulatory Agency (ANVISA) has published a crucial update that directly impacts the industry and regulated sector, bringing more clarity and legal certainty to certification processes. From now on, the way the [...]

Newsletter

Leave your e-mail in the field below to register in our newsletter and receive news and tips from Passarini every week.

Go to Top